Jaceidin Inhibits Proliferation and Promotes Apoptosis in Oral Squamous Cell Carcinoma Cells by Regulating Survivin and AKT/ERK Signaling Pathways
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177871 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ming-Ju Hsieh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Oral Cancer Research Center, Changhua Christian Hospital, Changhua 50006, Taiwan. Hauptthemen laut MEDLINE: Apoptosis, Proto-Oncogene Proteins c-akt, Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changhua Christian Hospital.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) remains a clinically challenging malignancy because of recurrence, treatment resistance, and limited therapeutic efficacy in advanced disease. This study investigated the anticancer effects and molecular mechanisms of jaceidin (JAC), a naturally occurring flavonoid derivative, in human OSCC cells. SCC-1 and SCC-47 cells were treated with JAC, and cell viability, colony formation, cell cycle distribution, apoptosis, and apoptosis-related signaling pathways were examined. JAC reduced OSCC cell viability and colony formation in a dose- and time-dependent manner. It also induced G2/M cell cycle accumulation and decreased the expression of cyclin D1, cyclin E1, phosphorylated cdc2, and CDK2/4/6. Apoptosis analyses showed that JAC promoted caspase-dependent apoptotic signaling, as evidenced by increased cleavage of caspase-3, caspase-8, caspase-9, and PARP. JAC modulated death receptor-associated signaling, characterized by increased Fas, TRADD, and DR5 expression and caspase-8 cleavage, while the decoy receptors DcR2 and DcR3 were also upregulated. JAC also promoted mitochondrial apoptotic signaling by increasing Bax, Bak, and Bim expression while decreasing Mcl-1. In addition, JAC attenuated AKT and ERK1/2 phosphorylation, and pharmacological inhibition with LY294002 or U0126 further enhanced JAC-induced apoptotic signaling. Furthermore, JAC reduced survivin expression and attenuated survivin-mediated apoptotic resistance. These findings suggest that JAC suppresses OSCC cell survival in association with modulation of AKT/ERK–survivin signaling and caspase-dependent apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oral Cancer Research Center, Changhua Christian Hospital, Changhua 50006, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, National Chung Hsing University, Taichung 402202, Taiwan.
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404328, Taiwan.
- Department of Dental Technology and Materials Science, Central Taiwan University of Science and Technology, Taichung 406, Taiwan.
- Maitocon Laboratory, Tirupur 641604, India.
- Department of Otorhinolaryngology, Head and Neck Surgery, Changhua Christian Hospital, No. 135, Nanxiao St., Changhua 50006, Taiwan.
ORCID-Profile: Ming-Ju Hsieh, Hsin-Yu Ho, Chia-Chieh Lin
Förderung
- Changhua Christian Hospital
Zitieren
APA
Hsieh, M. J., Ho, H. Y., Lin, C. C., Kao, M. Y., Lo, Y. S., Chuang, Y. C., Velmurugan, B. K., & Chen, M. K. (2026). Jaceidin Inhibits Proliferation and Promotes Apoptosis in Oral Squamous Cell Carcinoma Cells by Regulating Survivin and AKT/ERK Signaling Pathways. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177871
Vancouver
Hsieh MJ, Ho HY, Lin CC, Kao MY, Lo YS, Chuang YC, et al. Jaceidin Inhibits Proliferation and Promotes Apoptosis in Oral Squamous Cell Carcinoma Cells by Regulating Survivin and AKT/ERK Signaling Pathways. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177871
BibTeX
@article{Hsieh2026,
author = {Hsieh, Ming-Ju and Ho, Hsin-Yu and Lin, Chia-Chieh and Kao, Min-Yun and Lo, Yu-Sheng and Chuang, Yi-Ching and Velmurugan, Bharath Kumar and Chen, Mu-Kuan},
title = {Jaceidin Inhibits Proliferation and Promotes Apoptosis in Oral Squamous Cell Carcinoma Cells by Regulating Survivin and AKT/ERK Signaling Pathways},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177871}
}
EUVIMED